Echopulse

no surgery-related risks
single session treatment
no scar

The ultimate treatment for thyroid nodules and breast fibroadenoma

ECHOPULSE® is the first robotic and 100% non-invasive solution for echotherapy treatment (High-Intensity Focused Ultrasound HIFU) of thyroid nodules and breast fibroadenoma. The therapeutic ultrasound is combined with a standard ultrasound beam to control the accuracy of the treatment. It can be operated by a single person in a nonsurgical environment. It leaves no scars and maintains the thyroid function and the integrity of the breast tissue.

Lang B.; 2 year efficacy of single-session HIFU ablation of benign thyroid nodules; European Society of Radiology, 2018
Kovatcheva, R.; Long-term efficacy of ultrasound-guided HIFU treatment of fibroadenoma. J Ther Ultrasound 5,1 2017

ECHOPULSE results for thyroid nodules

ECHOPULSE® echotherapy targets the nodule through thermoablation. The robot’s treatment head combines a therapeutic ultrasound probe with a linear one: The therapeutic ultrasound probe delivers the HIFU (High-Intensity Focused Ultrasound) beam and focusses it to concentrated the thermal energy to the target. The linear probe allows real-time image visualization for a precise energy deposit.

results thyroid echotherapy

Echotherapy results for fibroadenoma

Volume reductions of fibroadenoma after ECHOPULSE treatment can be expected to be around 70% after 12 months. Continued decrease in volume has been observed after this period.

Kovatcheva et al.; Ultrasound-guided high-intensity focused ultrasound treatment of breast fibroadenoma -a multicenter experience R. Journal of Therapeutic Ultrasound; 2015

How echotherapy works

ECHOPULSE® echotherapy targets the nodule through thermoablation. The robot’s treatment head combines a therapeutic ultrasound probe with a linear one: The therapeutic ultrasound probe delivers the HIFU (High-Intensity Focused Ultrasound) beam and focusses it to concentrated the thermal energy to the target. The linear probe allows real-time image visualization for a precise energy deposit.

The Theraclion commitments

IN-DEPTH TRAINING & CLINICAL COLLABORATION

PARTNERING IN PATIENT RECRUITEMENT AND RAMP-UP

PASSIONATE HIFU EXPERTS & SERVICE ENGINEERS AT YOUR SIDE

Outlook HIFU - immunotherapy combination trial Watch the presentation
Filter by

Learn more

For more information such as the technical datasheet, the product brochure or clinical publications please contact us. Ask us

Echopulse is a class IIb medical device (according to Directive 93/42/EEC) designed and marketed by Theraclion. Echopulse has received CE-mark for non-invasive treatment of breast fibroadenomas and thyroid nodules – CE n° 0120.  Before use, read the instruction for use carefully.